Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Accumulated Expenses: 2009-2012

Historic Accumulated Expenses for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $12.8 million.

  • Lexicon Pharmaceuticals' Accumulated Expenses rose 65.94% to $12.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $12.8 million, marking a year-over-year increase of 65.94%. This contributed to the annual value of $13.8 million for FY2011, which is 120.08% up from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Accumulated Expenses of $12.8 million as of Q3 2012, which was down 15.04% from $15.0 million recorded in Q2 2012.
  • In the past 5 years, Lexicon Pharmaceuticals' Accumulated Expenses registered a high of $15.0 million during Q2 2012, and its lowest value of $5.1 million during Q1 2009.
  • Moreover, its 3-year median value for Accumulated Expenses was $7.7 million (2011), whereas its average is $9.5 million.
  • Data for Lexicon Pharmaceuticals' Accumulated Expenses shows a peak YoY surged of 120.08% (in 2011) over the last 5 years.
  • Over the past 4 years, Lexicon Pharmaceuticals' Accumulated Expenses (Quarterly) stood at $5.6 million in 2009, then grew by 11.64% to $6.3 million in 2010, then skyrocketed by 120.08% to $13.8 million in 2011, then soared by 65.94% to $12.8 million in 2012.
  • Its Accumulated Expenses was $12.8 million in Q3 2012, compared to $15.0 million in Q2 2012 and $13.7 million in Q1 2012.